Javascript must be enabled to continue!
Upgrade pacemaker to CRT: predictors and the importance of LVEF
View through CrossRef
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Nowadays 10-15% of CRT implantaon is upgrading from paents (pts) with pacemaker (PMK) who develop reduced LVEF and worsening symptoms from HF. There are few retrospecve studies showing some predictors of pts with single or dual chamber PMK that may need upgrade to CRT, but it is not completely established which pts may benefit the most.
Purpose
To identify predictors at follow-up of upgrading pacemaker to CRT in a population with pacemaker implantation.
Methods
Single center case-control study of pts that performed upgrading to CRT-pacemaker (CRT-P) in our hospital. We excluded pts that performed upgrade to CRT-D. We compare to a PMK populaon matched to age at implantaon and cause of PMK implantaon. Demographic, clinic and electrocardiographic (ECG) data were considered at baseline. Echocardiographic evaluation was performed before pacemaker/CRT upgrading implantaon and at follow-up. Predictors of upgrading were evaluated by the Cox regression. Prognosc impact of LVEF was evaluated as upgrading to CRT-P by Kaplan-Meier curves.
Results
We included 71 pts that performed CRT-P upgrade (mean age 77±10; 49,6% male, mean LVEF before PMK 54.9±9.2%) and 71 pts with pacemaker implantaon (mean age 78 ± 11; 50,4% male; mean LVEF 60.9±7.2%). The clinical characteriscs, ECG and echocardiographic were similar between pacemaker and CRT-P-upgrade, except atrial fibrillaon being more prevalent in PMK group (57.5% vs 42.5% p=0.039). Mortality was not different duringfollow-up between the two groups. In univariate analysis, QRS duraon (PMK: 115ms vs upgrade CRT-P: 132 ms, p=0.038), LVEF (PMK: 60.9% vs upgrade CRT-P: 54.9%, p=0.002) and LV end-diastolic diameter (LVEDD) (PMK: 48.9.4 ± 6.6mm vs upgrade CRT-P: 56.4 ± 6.6mm, p=0.001), LV end-sistolic diameter (LVESD) (PMK: 29.5 ± 6.5mm vs upgrade CRT-P: 37.9 ± 9 mm, p=0.006) were associate to upgrading to CRT. In our population, the unique independent predictor was lower LVEF(Long Rank 6.108, p=0.013) – Figure 1. The best LVEF cut- off to predict upgradingto CRT was 55% (AUC 0.954, sensitivity 64%, specificity 84%) – Figure 2.
Conclusion
In our populaon of CRT upgrading pts, a broad QRS duraon, lower LVEF and a higher LVEDD and LVESD were associated to upgrade to CTR-P. We try to establish a new value for LVEF that could lead to upgradingto CRT-P, and maybe the classical cut-off of 50% should be reviewed.
Oxford University Press (OUP)
Title: Upgrade pacemaker to CRT: predictors and the importance of LVEF
Description:
Abstract
Funding Acknowledgements
Type of funding sources: None.
Introduction
Nowadays 10-15% of CRT implantaon is upgrading from paents (pts) with pacemaker (PMK) who develop reduced LVEF and worsening symptoms from HF.
There are few retrospecve studies showing some predictors of pts with single or dual chamber PMK that may need upgrade to CRT, but it is not completely established which pts may benefit the most.
Purpose
To identify predictors at follow-up of upgrading pacemaker to CRT in a population with pacemaker implantation.
Methods
Single center case-control study of pts that performed upgrading to CRT-pacemaker (CRT-P) in our hospital.
We excluded pts that performed upgrade to CRT-D.
We compare to a PMK populaon matched to age at implantaon and cause of PMK implantaon.
Demographic, clinic and electrocardiographic (ECG) data were considered at baseline.
Echocardiographic evaluation was performed before pacemaker/CRT upgrading implantaon and at follow-up.
Predictors of upgrading were evaluated by the Cox regression.
Prognosc impact of LVEF was evaluated as upgrading to CRT-P by Kaplan-Meier curves.
Results
We included 71 pts that performed CRT-P upgrade (mean age 77±10; 49,6% male, mean LVEF before PMK 54.
9±9.
2%) and 71 pts with pacemaker implantaon (mean age 78 ± 11; 50,4% male; mean LVEF 60.
9±7.
2%).
The clinical characteriscs, ECG and echocardiographic were similar between pacemaker and CRT-P-upgrade, except atrial fibrillaon being more prevalent in PMK group (57.
5% vs 42.
5% p=0.
039).
Mortality was not different duringfollow-up between the two groups.
In univariate analysis, QRS duraon (PMK: 115ms vs upgrade CRT-P: 132 ms, p=0.
038), LVEF (PMK: 60.
9% vs upgrade CRT-P: 54.
9%, p=0.
002) and LV end-diastolic diameter (LVEDD) (PMK: 48.
9.
4 ± 6.
6mm vs upgrade CRT-P: 56.
4 ± 6.
6mm, p=0.
001), LV end-sistolic diameter (LVESD) (PMK: 29.
5 ± 6.
5mm vs upgrade CRT-P: 37.
9 ± 9 mm, p=0.
006) were associate to upgrading to CRT.
In our population, the unique independent predictor was lower LVEF(Long Rank 6.
108, p=0.
013) – Figure 1.
The best LVEF cut- off to predict upgradingto CRT was 55% (AUC 0.
954, sensitivity 64%, specificity 84%) – Figure 2.
Conclusion
In our populaon of CRT upgrading pts, a broad QRS duraon, lower LVEF and a higher LVEDD and LVESD were associated to upgrade to CTR-P.
We try to establish a new value for LVEF that could lead to upgradingto CRT-P, and maybe the classical cut-off of 50% should be reviewed.
Related Results
Autonomic nervous system driven resynchronization therapy using left ventricular only pacing with electrocardiographic optimization. A new paradigm. 9+ month follow-up of dual chamber systems
Autonomic nervous system driven resynchronization therapy using left ventricular only pacing with electrocardiographic optimization. A new paradigm. 9+ month follow-up of dual chamber systems
Abstract
Background
LV-only (LVo) CRT was recognized in the 2013 ESC guidelines [1] as non-inferior to biventricular (biV) CRT i...
Left-ventricular-only cardiac resynchronization therapy with electrocardiographic optimization: 100-day follow-up
Left-ventricular-only cardiac resynchronization therapy with electrocardiographic optimization: 100-day follow-up
Abstract
Background
LV-only (LVo) cardiac resynchronization therapy (CRT) was recognized in 2013 as a non-inferior alternative t...
Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
Outcomes of cardiac resynchronisation therapy in patients with heart failure with atrial fibrillation: a systematic review and meta-analysis of observational studies
Background
Cardiac resynchronisation therapy (CRT) is beneficial in selected patients with heart failure (HF) in normal sinus rhythm (NSR). We sought to evaluate ...
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy
Development and Internal Validation of a Prediction Model for Nasopharyngeal Carcinoma: Using BMI and Inflammatory Response for Deciding Sequence of Chemotherapy
PURPOSE Concurrent chemoradiotherapy followed by adjuvant chemotherapy (CRT-AC) and induction chemotherapy followed by concurrent chemoradiotherapy (IC-CRT) are among the best trea...
GW24-e3774 Therapeutic effect of cardiac resynchronisation therapy about congestive heart failure
GW24-e3774 Therapeutic effect of cardiac resynchronisation therapy about congestive heart failure
Objectives
The aim of this study is to observe the effect of 12 months after therapy of CRT in patients with congestive heart failure, to investigate the change o...
Conduction system versus biventricular pacing upgrade in patients with pacing-induced cardiomyopathy
Conduction system versus biventricular pacing upgrade in patients with pacing-induced cardiomyopathy
Abstract
Background
The feasibility and outcome of conduction system pacing (CSP) upgrade as an alternative modality to the trad...
Cardiac resynchronosation and left ventricular ejection fraction improvement with single ventricular conduction pacing system lead
Cardiac resynchronosation and left ventricular ejection fraction improvement with single ventricular conduction pacing system lead
Abstract
Background
Conduction system pacing is a new modality to obtain physiologic pacing (PP) and normal to near normal cardi...
Impact of non-typical LBBB on CRT response
Impact of non-typical LBBB on CRT response
Abstract
Introduction
Cardiac resynchronization therapy (CRT) benefits have been established in patients with heart failure and ...

